Clariant has cut its ties with the life sciences industry and will
no longer offer custom manufacturing services in this arena after
the sale of the last piece of its Lifesciences division.
Despite a 3 per cent drop in sales to SFr8.181bn (€5.212bn),
specialty chemicals maker Clariant has posted a 29 per cent rise in
net profit for 2005 to SFr192m, thanks to lower interest charges,
currency gains and lower taxes, but...
In the second part of a special report, In-PharmaTechnologist has
taken a closer look at the Pharmaceutical Fine Chemicals Business
of Clariant, which made a series of announcements on new
investments in facilities in Europe and the...
Clariant has announced plans to establish a Technology Centre in
Germany that will support the pharmaceutical industry in the
commercialisation of new drugs.
Aldo Magnini has been appointed managing director of Clariant's
pharmaceuticals ingredients manufacturing business in Italy, based
around the company's two manufacturing plants in Origgio and Isso.
